GRIS-PEG Drug Patent Profile
✉ Email this page to a colleague
When do Gris-peg patents expire, and what generic alternatives are available?
Gris-peg is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in GRIS-PEG is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gris-peg
A generic version of GRIS-PEG was approved as griseofulvin, ultramicrosize by MOUNTAIN on January 9th, 2014.
Summary for GRIS-PEG
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 52 |
Patent Applications: | 106 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for GRIS-PEG |
What excipients (inactive ingredients) are in GRIS-PEG? | GRIS-PEG excipients list |
DailyMed Link: | GRIS-PEG at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GRIS-PEG
US Patents and Regulatory Information for GRIS-PEG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | GRIS-PEG | griseofulvin, ultramicrosize | TABLET;ORAL | 050475-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | GRIS-PEG | griseofulvin, ultramicrosize | TABLET;ORAL | 050475-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |